Plasma CCL3 predicts adverse heart failure outcomes in patients with arrhythmogenic cardiomyopathy. - Cui, Hao; Shu, Songren; Zhang, Ningning; Wang, Mangyuan; Yang, Tianshuo; Wang, Zhen; Chen, Xiao; Fu, Mengxia; Xu, Mengda; Yang, Yicheng; Wang, Peizhi; Wang, Chuangshi; et al. (BMC Medicine, 2025)